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Abstract
Aims-To examine the prognostic and
pathobiological importance of DNA con-
tent in oesophageal squamous cell carci-
nomas in Hong Kong Chinese subjects; to
evaluate its association with the immuno-
histochemical proliferative marker
MIB-1.
Methods-Paraffin wax embedded tu-
mour tissue and adjacent normal tissue
(control tissue) samples from 45 resected
stage III oesophageal squamous cell carci-
nomas were studied using flow cytometric
analysis. The DNA content and the clin-
icopathological data ofthese patients were
analysed together with the MIB-1 label-
ling index.
Results-DNA aneuploidy was present in
14 (31%) of the 45 cases. However, the
DNA content did not correlate signifi-
cantly with the age, sex, or survival of the
patients, nor the length, location, differen-
tiation and MIB-1 labelling index of the
oesophageal carcinomas. The synthetic
(S) phase fraction ofdiploid tumours bore
no relation to the patients' survival or
MIB-1 score.
Conclusions-Flow cytometry was not as
useful as the MIB-1 labelling index in pre-
dicting the biological characteristics of
the tumours and the prognosis of patients
with oesophageal squamous cell carcino-
mas. This study does not support the rou-
tine use of DNA flow cytometric analysis
in oesophageal cancers.
(7 Clin Pathol 1996;49:975-978)
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An association between proliferative activity
and overall prognosis has been noted in many
cancers, and several studies have been pub-
lished on the objective determination of cell
proliferation using mainly either immunohisto-
chemical methods or flow cytometry.1' We
recently demonstrated the important role of
the MIB-1 labelling index (using an immuno-
histochemical method) in relation to the grade
of oesophageal squamous cell carcinoma and
prognosis.3 Flow cytometric DNA analysis, on
the other hand, has never been investigated in
Hong Kong, although it is claimed to be more
objective, precise, and quantitative (measuring
large numbers of cells) than histological
assessment, in the study ofmany cancers.4 The
purpose of this study was to identify the corre-
lation between the results of flow cytometry
and a number of clinicopathological variables,
including prognosis in Hong Kong Chinese
patients with squamous cell carcinoma of the
oesophagus, and to compare the efficacy of
flow cytometry with the MIB-1 labelling index.
Method
Oesophageal tissues were collected prospec-
tively from Chinese patients who had had
oesophageal cancers treated by resection in
Queen Mary Hospital, Hong Kong (a major
referral centre for patients with oesophageal
cancers) between January 1989 and December
1993. The samples from the oesophageal
tumours and control tissue were obtained
fresh, fixed in 10% formalin for less than 48
hours, processed and embedded in paraffin
wax. In each case sections were cut and stained
with haematoxylin and eosin and examined
microscopically. The tumours were staged
according to the tumour nodes metastases
(TNM) classification.5 Tissue from patients
with stage III squamous cell carcinomas were
chosen for DNA measurement. One
representative block from the tumour and one
from the non-neoplastic tissue distal to the
tumour were taken from each case for flow
cytometric analysis. The tumour block used
was the one in which the dominant histological
pattern of each carcinoma was identified
(because a few carcinomas showed slight varia-
tions in tumour differentiation in different foci
of the tumours). The non-tumour blocks were
processed simultaneously with the tumour
blocks as an external check on instrument cali-
bration, and as a control for specimen process-
ing and staining.
The clinicopathological features of the cases
were assessed. The age and sex of the patients
as well as the site and the size (represented by
the maximum longitudinal measurement) of
the tumour were identified. The squamous
carcinomas were graded into well, moderately,
and poorly differentiated carcinomas according
to World Health Organisation criteria.6 The
survival of the patients was measured from the
date of resection to the dates of death or to the
dates of last follow up.
Paraffin wax sections (46 ,um) from each
chosen block were cut, dewaxed in xylene, and
rehydrated in descending grades of alcohol and
distilled water. The tissues were centrifuged at
1800 rpm and the supernatant fluid poured
off. The pellet in each case was digested in 1 ml
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0.5% pepsin (Sigma P-6887, USA) in 0.9%
sodium chloride at pH 1.5, and incubated in a
water bath at 37°C with intermittent shaking
for one hour. The suspension in each case was
centrifuged at 1800 rpm for five minutes. The
supernatant fluid was poured off and the pellet
was washed twice in phosphate buffered saline
(PBS) and resuspended in 1 ml PBS. The
solution was filtered through nylon wool and
the supernatant fluid removed by centrifuga-
tion, as before. The pellet was treated with
equal parts 0.01% deoxyribonuclease free
ribonuclease (Sigma R-5503, USA) and 0.01%
propoidium iodide (Sigma P-4170, USA) at
37°C and shaken for 30 minutes. The solution
was then centrifuged, the supernatant fluid
discarded, the pellet resuspended in PBS and
the specimen taken for DNA measurement.
The DNA content was measured using a
laser based, multiparameter flow cytometer
(EPICS Profile II System, Coulter, Hialeah,
Florida, USA), computed, and analysed using
Multi-cycle Cell Cycle Analysis Software
(Phoenix Flow Systems, San Diego, California,
USA). More than 15 000 cells were counted in
each case. The specimens were classified into
diploid and aneuploid categories according to
their DNA index (DI) noted in the DNA
histograms generated from the software. The
samples with a DI of 0.9 to 1.1 were classified
as diploid (fig 1) while those with a DI of more
than 1.1 or less than 0.9 were classified as
aneuploid (fig 2). Samples from the malignant
tumours containing less than 20% tumour cells
were considered unsuitable for evaluation and
excluded from the study. The coefficient of
variation (CV) of the GO/GI peak of each sam-
ple and the synthetic (S) phase fraction (the
fraction of cells between the GO/GI peak and
the small G2 + M peaks) of the diploid samples
were also calculated from the histograms using
the software. The CV is defined as the standard
deviation (SD) divided by the mean. It is used
to compare distributions and is often used as a
measure of the quality of staining and instru-
ment analysis. Samples were excluded from the
study when the CV of the DNA GO/Oil diploid
peak was 10% or greater.
The MIB-1 stained sections were counted at
x 400 magnification. At least 1000 nuclei were
counted in each section, as described before.3
The MIB-1 score was presented as the number
of positively stained nuclei per 1000 nuclei
counted.
The results of clinicopathological assess-
ment, survival analysis, DNA measurement
and MIB-1 score of these cancers were
computed. Statistical tests were performed
using the SAS statistical package; test results
were considered significant when a p value of
less than 0.05 was obtained.
Results
Forty five patients (37 men, eight women) with
oesophageal cancer (13 well, 24 moderately,
and eight poorly differentiated) were included
in the study. The mean age of the patients was
64 years (range 47 to 78 years). The mean
length of the lesions was 5.5 cm (range 1 to 11
cm). The carcinomas were located in the upper
2800 r
2400
2000
-)
E)
1600
1200
800
400
n
i1
- I:
.,
.,It
.1
1:r1
,RI
1:. J~
agL--l
I I
0 40 80 120
FL3
160 200 240
Figure 1 Histogram ofDNA distribution: DNA diploid
pattern (DI=1). The diploid tumour has one distinctive
GOIG, peak and a tiny G2+M peak. The FL3 channel
number of the G2+Mpeak is double that of the GO/G,
peak. (FL3= relativefluorescence light intensity which
represents the relative DNA content; Go/G1, G2+M =
phases in the cell cycle).
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Figure 2 Histogram ofDNA distribution: DNA
aneuploid pattern (DI=1. 6). The aneuploid tumour has
two distinctive GOIG1 peaks. The second peak comprises a
substantial proportion of cells (much larger than the G2+M
peak in the diploid pattern). The FL3 channel number of
the second peak is > 1 but is less than twice that of the first
peak. (FL3=relative fluorescence light intensity which
represents the relative DNA content; GOIGI, G2 +M =
phases in the cell cycle).
portion of the oesophagus in four (9%)
patients, the central portion in 24 (53%), and
the lower portion in 17 (38%). All follow up
data from the patients were available and the
mean follow up period for the whole group was
17 months. Forty (89%) patients had died at
the time of data analysis.
Sixty nine per cent (31 cases) of the tumours
were diploid while 31% (14 cases) were aneu-
ploid. The clinicopathological data of patients
with diploid and aneuploid tumours are listed
in table 1. The DNA ploidy of the tumours did
not correlate with the sex (p=0.69, Fisher's
exact test) or age of the patients (p=0.29,
t-test). Neither did it show any correlation with
the longitude (p=0.58, t-test), location
(p=0.52, X2 test) or MIB-1 score (p=0.73,
t-test) of the tumours. Although diploid
tumours were more differentiated (35%) than
aneuploid tumours, there was no obvious
difference in DNA content and histological
grade (p=0.073).
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Table I Clinicopathological data of squamous carcinomas
of the oesophagus: aneuploid and diploid cases
Clinicopathologicalfeatures Aneuploid cases Diploid cases
No of patients 14 31
Average age 65 63
Male/female 11/3 (3:1) 26/5 (5:1)
Mean longitudinal length 5.7 cm 5.4 cm
Site:
Upper 1 (7%) 3 (10%)
Middle 6 (43%) 18 (58%)
Lower 7 (50%) 10 (32%)
Differentiation:
Well 2 (25%) 11 (35%)
Moderate 7 (58%) 17 (55%)
Poor 5 (17%) 3 (10%)
Mean MIB-1 score 553 578
The survival curves of the patients with dip-
loid and aneuploid carcinomas are displayed in
fig 3. Although patients with aneuploid stage
III oesophageal squamous cell carcinomas
seemed to have a slightly better prognosis,
there was no significant difference in cumula-
tive survival between the two groups (p=0.23,
Wilcoxon test).
The S phase could only be calculated for the
diploid tumours. It ranged from 3.1% to
55.3%. The resulting S phase value in these
tumours bore no relation to either the survival
of the patients (p=0.064, Spearman correlation
coefficients) or the MIB-1 labelling index
(p=0.43, Spearman correlation coefficients).
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Figure 3 Survival ofpatients with diploid and aneuploid
squamous cell carcinoma of the oesophagus.
Discussion
In this study an attempt was made to obtain
more reliable results by limiting the value of an
acceptable CV of the GO/GI peak to less than
10%, counting a minimum of 15 000 cells and
using normal tissue in each case to act as a
standard for staining and instrument control.
We used paraffin wax sections because: (1) they
are easier to obtain and handle than frozen tis-
sues; (2) they can prevent contamination with a
large number of normal cells by selecting the
appropriate paraffin wax block with enough
tumour tissue from the many blocks available.
Only one frozen tumour block was available for
each case and the quality of the section for
interpretation was not as good as that found in
paraffin wax sections; and (3) several studies
have shown that equivalent results may be
obtained from both paraffin wax and frozen
sections in most instances, although significant
variations occur among some laboratories.78
A review of the published series on flow
cytometric analysis of DNA content in
oesophageal squamous cell carcinomas is
shown in table 2.9- ' The prevalence of
aneuploid tumours detected in these studies
varied from 31% to 82%. In these studies
(including the present survey), DNA ploidy in
oesophageal tumours was not related to either
the age or sex of the patients nor to location or
length of the tumours.9' 12 The correlation
between ploidy and grade in oesophageal
squamous cell carcinomas has not been estab-
lished. Besides, Yu et al9 and Doki et al 7
reported that aneuploid tumours were less dif-
ferentiated than diploid tumours, but in many
other series (including this one), such differ-
ences have not been confirmed.'0-13 20
Yu et al9 and Robey-Cafferty et al13 showed
that aneuploid oesophageal tumours were
often more advanced than diploid tumours, but
other authors did not show similar
findings.'0 13 16 20 It is nevertheless worth noting
that in our previous study, the prognosis of
patients with oesophageal cancer depended
strongly on the stage ofthe tumour.3 This study
was limited to stage III oesophageal squamous
cell carcinomas, to eliminate the effect of
tumour stage on prognosis. In our experience
most tumours were stage III at the time of sur-
gery.
Table 2 Studies on flow cytometric analysis ofDNA content in oesophageal squamous cell carcinomas
Author (year) Place No % A CV Cell a T Normal c Remarks
Yu (1989)9 China 36 69 5% 10000 F Yes
Edwards (1989)10 UK 100 70 10% 20000 P
Katetani (1989)" Japan 31 74 10% 20000 P
Mannell (1990)12 South Africa 42 79 25000 P
Robey-Cafferty USA 52 79 P
(1991)13
Sasaki (1991)14 Japan 23 87 3% 10000 P
Dorman (1992)'5 UK 27 37 10% 20000 P Yes All at same stage (stage 2A) and
grade
Patil (1993)16 India 74 81 P
Doki (1993)'7 Japan 103 56 30000 P
Goukon (1994)18 Japan 33 82 P
Flejou (1994)'9 France 73 67 9% F
Haraguchi (1995)20 Japan 40 71 8% 10000 P All superficial carcinomas
Lam (1996) Hong Kong 45 31 10% 15000 P Yes All stage 3 lesions
% A: % of aneuploid tumours; No: number of patients studied; CV: maximum value of coefficient of variation of GO/G, phase
accepted for analysis; T: type of tissue used; P: paraffin wax; F: frozen; Cell a: minimum number of cells analysed accepted for
analysis; Normal c: presence of normal tissue from each patient to act as a control.
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Studies so far have shown conflicting results
with regard to the value of DNA ploidy as a
prognostic marker.2' In many solid tumours a
diploid DNA pattern is usually associated with
a favourable prognosis while DNA aneuploidy
is associated with poor survival. In oesophageal
cancers the relation between DNA ploidy and
survival is even less clear. Of the few studies
which have been performed, most have shown
that flow cytometric DNA analysis was not
useful in predicting patients' survival. 12 13 15 16
For instance, Mannell et all' detected a higher
recurrence rate while Doki et al'7 demonstrated
poorer survival in patients with aneuploid
tumours. In contrast, Edward et al'0 observed
that if only tumours confined to submucosa or
muscle wall (stage M/II tumours) were assessed,
patients with diploid tumours had a poorer
survival than those with aneuploid tumours.
In Hong Kong, we noted that there was no
significant difference between the survival of
patients with either diploid or aneuploid
tumours, although diploid tumours seemed to
have a slightly poor survival than aneuploid
tumours. The association between DNA dip-
loid lesions and poorer survival reported by
Edwards et al' is actually not surprising as the
explanation may be related to the theory that
aneuploidy might disrupt or diminish rather
than enhance the proliferation and spread of
cancer cells.22
Both flow cytometric and immunohisto-
chemical methods have been used in the deter-
mination of cell proliferation. 1 2 In our previous
study we documented the usefulness of the
immunohistochemical stain, MIB-1, as an
objective marker of tumour differentiation and
a potential prognostic indicator in oesophageal
squamous cell carcinoma.3 The current investi-
gation, however, has failed to show any signifi-
cant correlation between the S phase fraction/
DNA ploidy and MIB-1. The counting of
MIB-1 labelled nuclei seems to be better than
flow cytometry in the objective assessment of
the clinicopathological variables of oesopha-
geal cancers.
In conclusion, flow cytometric analysis did
not show any meaningful correlation with clin-
icopathological factors and prognosis. Flow
cytometric analysis of DNA is also time
consuming, depends heavily on technical
expertise, and the initial cost of the flow
cytometer is high. We therefore do not support
the routine use of flow cytometry in the study
ofsquamous cell carcinomas ofthe oesophagus
in our population.
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